Long-term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism
about
Surgical management of secondary hyperparathyroidism in chronic kidney disease--a consensus report of the European Society of Endocrine Surgeons.Failed Switching off in the MIBI-Parathyroid Scintigraphy in a Dialyzed Patient with Secondary Hyperparathyroidism Responsive to Cinacalcet Therapy.Cinacalcet effectively reduces parathyroid hormone secretion and gland volume regardless of pretreatment gland size in patients with secondary hyperparathyroidism.An open-label study to evaluate a single-dose of cinacalcet in pediatric dialysis subjects.Pharmacogenetic analysis of cinacalcet response in secondary hyperparathyroidism patients.Pharmacotherapy and interventional treatments for secondary hyperparathyroidism: current therapy and future challenges.Clinical utilization of cinacalcet in hypercalcemic conditions.Mineral and bone disorders in children with chronic kidney disease.Pharmacotherapy of chronic kidney disease and mineral bone disorder.Cinacalcet: will it play a role in reducing cardiovascular events?Review of cinacalcet hydrochloride in the management of secondary hyperparathyroidism.Cinacalcet and Clinical Outcomes in Dialysis.Prospective cohort study: Cinacalcet-mediated lowering of PTH level and cardiovascular disease mortality in younger Korean patients with stage 5 CKD at a Korean secondary hospital.Clinical impact of hypercalcemia in kidney transplant.Cinacalcet is effective in the treatment of hyperparathyroidism secondary to malignant transformation of autotransplanted parathyroid tissue. A case report.Impact of cinacalcet pre-transplantation on mineral metabolism in renal transplant recipients.Save life and improve quality: report from the 5th Congress of International Society for Hemodialysis.Cinacalcet HCl prevents development of parathyroid gland hyperplasia and reverses established parathyroid gland hyperplasia in a rodent model of CKD.Risk-factors for nodular hyperplasia of parathyroid glands in sHPT patients.Early initiation of cinacalcet for the treatment of secondary hyperparathyroidism in hemodialysis patients: a three-year clinical experience.Parathyroid Nodular Hyperplasia and Responsiveness to Drug Therapy in Renal Secondary Hyperparathyroidism: An Open Question.Cinacalcet induces apoptosis in parathyroid cells in patients with secondary hyperparathyroidism: histological and cytological analyses.Two Years of Cinacalcet Hydrochloride Treatment Decreased Parathyroid Gland Volume and Serum Parathyroid Hormone Level in Hemodialysis Patients With Advanced Secondary Hyperparathyroidism.
P2860
Q30316084-32C7FAF5-FF20-494F-B9BF-984D10A78A4AQ34002025-D76876F6-9DF1-4B41-92E8-6829D1DB6FE6Q34362759-0BFE6E30-37EC-4652-8007-5C2CA8B3A454Q36173980-178FD279-F2EF-48AD-86A6-39FA52C038F1Q37095019-C26E588F-B215-4B1D-A146-AF07DE2215E8Q37807991-9DA6C910-EEB7-451F-B5AA-8A5F77FBAFB3Q37848439-840F5F09-0D00-438A-B039-F93CC2948840Q37938689-07E1D02A-BA5A-4650-8722-551C013CBB44Q37948105-E82CBD6C-42DA-45B5-88BA-F0232DD8F233Q37993874-F29A4BF0-149F-46A4-B93F-EB4A441C4569Q38141236-329D7EE3-BEF7-4629-BE52-BD921E0240A7Q38565049-7CB14D98-25A4-48BF-A372-A2AF3CCE4183Q38741434-511ACECD-B83D-44CD-822F-B7275C126944Q39728456-47C07C17-4C2B-41B2-A99E-A19C165E0EC0Q41086630-280B60C0-7677-4E9F-8F73-24FD96250E0BQ41671380-7F191026-F176-4D69-BD19-441E3E69E860Q41968095-42F4A005-4F41-4676-9F7B-90B1852A5884Q42181616-75B3ED77-D75C-4B9B-B722-DE2CEDE079B7Q42685461-127F53CC-4E46-42EA-8B0F-AA7540F6165BQ43826461-0F9727D7-0916-4A6C-96D8-970F5045BE20Q48239717-16F5A555-2BD1-41FD-839B-B55FFA4D4947Q53067680-668CA490-CC94-482F-9B5B-97BB1F778C33Q53551519-12F7C3E9-F899-4047-B5F1-1A984E6E38A5
P2860
Long-term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Long-term treatment with cinac ...... secondary hyperparathyroidism
@en
Long-term treatment with cinac ...... secondary hyperparathyroidism.
@nl
type
label
Long-term treatment with cinac ...... secondary hyperparathyroidism
@en
Long-term treatment with cinac ...... secondary hyperparathyroidism.
@nl
prefLabel
Long-term treatment with cinac ...... secondary hyperparathyroidism
@en
Long-term treatment with cinac ...... secondary hyperparathyroidism.
@nl
P2093
P2860
P356
P1476
Long-term treatment with cinac ...... secondary hyperparathyroidism
@en
P2093
Giuliano Barsotti
Ilaria Petrucci
Mario Meola
P2860
P304
P356
10.1093/NDT/GFN654
P407
P577
2009-01-30T00:00:00Z